clomipramine has been researched along with Muscular Dystrophy in 2 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ogata, K | 1 |
Kohno, S | 1 |
Yatabe, K | 1 |
Komiya, T | 1 |
Kawai, M | 1 |
Stahl, SM | 1 |
Meltzer, HY | 1 |
2 other studies available for clomipramine and Muscular Dystrophy
Article | Year |
---|---|
[The effect of clomipramine to nocturnal periodic hypoxemia in Duchenne muscular dystrophy].
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Drug Tolerance; Humans; Hypoxia; Male; Muscul | 1996 |
Serotonin accumulation by skeletal muscle.
Topics: Animals; Biological Transport; Chlorpheniramine; Chlorpromazine; Clomipramine; Dose-Response Relatio | 1977 |